Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATIE Alzheimer's Disease Trial
NCT00015548Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine, quetiapine, risperidone, citalopram in Alzheimer's disease (AD), sponsored by National Institute of Mental Health. Started Mar 2001; status: completed.
02
Drugs
olanzapinequetiapinerisperidonecitalopram
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00015548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015548.